MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Effects of thalamic deep brain stimulation on focal hand dystonia

    T. Hashimoto, J. Tanimura, T. Yako (Matsumoto, Japan)

    Objective: To confirm the effectiveness of thalamic DBS on focal hand dystonia, the outcome of thalamic DBS was analyzed in 4 patients with focal hand…
  • 2023 International Congress

    Clinical and radiological characteristics of elder patients of Parkinson’s disease with the onset age of more than 80 years old

    M. Nomoto, H. Iwaki, R. Nonaka, N. Yano (Imabari, Ehime, Japan)

    Objective: We investigated clinical and radiological findings of elder PD patients with the onset of more than 80 years old using clinical examinations, brain CT/MRI…
  • 2023 International Congress

    Hesperidin ameliorates rotenone-induced Parkinson’s disease in mice via improving neuroinflammation and oxidative stress

    D. Singh (Prayagraj, India)

    Objective: The goal of the present study is to examine the neuroprotective property of hesperidin on rotenone-induced Parkinson's disease in mice. Background: The second most…
  • 2023 International Congress

    Effect of Best Practice Advisory on the administration of contraindicated medications to hospitalized patients with Parkinson’s disease and related disorders

    N. Chunga, K. Amodeo, M. Braun, B. Valdovinos, I. Richard (Rochester, USA)

    Objective: To determine if a best practice advisory (BPA) reduced the orders and administration of contraindicated dopamine blocking agents (DBA) to hospitalized patients with Parkinson’s…
  • 2023 International Congress

    Phenotypic characterization of 104 patients with Progressive Supranuclear Palsy: A Tertiary care experience from South India

    R. Yadav, S. Dey, N. Kamble, V. Holla, R. Mahale, M. Debnath, P. Pal (Bangalore, India)

    Objective: To prospectively evaluate and subtype the patients of Progressive supranuclear palsy being referred to a tertiary care movement disorders facility in South India. Background:…
  • 2023 International Congress

    Fluorescence-lifetime ophthalmoscopy findings in Parkinson’s disease patients with visual disturbances

    K. Shivok, E. Affel, M. Alizadeh, T-W. Liang, D. Kremens, R. Sergott (Philadelphia, USA)

    Objective: We identified fluorescence-lifetime ophthalmoscopy changes in Parkinson’s disease (PD) patients experiencing visual disturbances. Background: Fluorescence-lifetime ophthalmoscopy (FLIO), a novel in vivo imaging method generating…
  • 2023 International Congress

    Genetics of Parkinson’s Disease in Polish patients with positive family history-preeliminary study.

    L. Milanowski, D. Hoffman-Zacharska, M. Geremek, S. Szlufik, A. Friedman, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of our study was to find genetic variants associated with the familial forms of Parkinson’s disease (PD) in Polish population. Background: PD…
  • 2023 International Congress

    Genetic polymorphisms associated with nigrostriatal dopaminergic depletion as measured with [I123]-FP-CIT SPECT in Parkinson’s disease

    S. Castro Labrador, MA. Labrador Espinosa, J. Silva Rodríguez, D. García Solís, P. Mir, MJ. Grothe (Seville, Spain)

    Objective: To conduct a genome-wide association study (GWAS) of striatal [I123]-FP-CIT SPECT signal as endophenotype to explore possible associations between genetic background and nigrostriatal dopaminergic…
  • 2023 International Congress

    Anti-tremor efficacy of Nabiximols (JZP378) in a rat Model of essential tremor

    S. Loomis, E. Samoylenko, D. Virley, A. Mccreary (Cambridge, United Kingdom)

    Objective: To assess the effect of acute and subchronic oral administration of nabiximols (JZP378), a complex botanical cannabinoid drug mixture with Δ9-tetrahydrocannabinol (THC) and cannabidiol…
  • 2023 International Congress

    Short-term effect of continuous positive airway pressure in MSA patients with sleep disordered breathing

    G. Lazzeri, M. Houot, M. Patout, F. Cormier, M. Vidailhet, JC. Corvol, I. Arnulf, D. Grabli, P. Dodet (Milan, Italy)

    Objective: SBD are frequent in MSA, mainly represented by inspiratory stridor, obstructive and central sleep apnea/hypopnea syndrome (SAS), or hypopneaimpacting the quality of sleep. A…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley